Kusajili – Clinical trials directory

Result of your search per sponsor: Prakash Chinnaiyan, M.D

Woman and Man Max 99 years
Prakash Chinnaiyan, M.D Update Il y a 4 ans

A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma The purpose of the this study is to see if an investigations cancer treatment called vorinostat can be combined with the irinotecan/bevacizumab regimen safely.

Country United States
organs None
Specialty None

Closed trial

More information